Overview

Efficacy of ActiveMatrix on Spinal SSI Rate

Status:
Not yet recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
This clinical trial seeks to provide high level of evidence on the efficacy of ActiveMatrix primarily on spinal surgical site infection rate.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
Skye Biologics